Imanova Receives More Medical Research Council Funding for MIND-MAPS Study
United Kingdom-based Imanova has received £1 million ($1.2 million U.S.) of strategic Medical Research Council (MRC) funding to clinically evaluate new positron emission tomography (PET) imaging tracers for measuring mitochondrial dysfunction and synaptic loss associated with Alzheimer’s and Parkinson’s diseases. Imanova previously had received a £0.5 million $623,000 U.S.) MRC grant…